Zacks Investment Research Upgrades eMagin (NYSEAMERICAN:EMAN) to Hold

Zacks Investment Research upgraded shares of eMagin (NYSEAMERICAN:EMAN) from a sell rating to a hold rating in a research report report published on Wednesday morning, Zacks.com reports.

According to Zacks, “eMagin Corporation is a leading developer of virtual imaging technology, eMagin combines integrated circuits, microdisplays, and optics to create a virtual image equivalent to the real image of a computer monitor or large screen TV. These miniature, high-performance, virtual imaging modules provide access to information-rich text, data, and video which can facilitate the opening of new mass markets for wearable PCs, wireless Internet appliances and mobile phones, portable DVD-viewers, digital cameras, and other emerging applications. “

Separately, HC Wainwright decreased their price objective on shares of GENFIT S A/ADR to $72.00 and set a buy rating for the company in a report on Monday, April 22nd.



Shares of NYSEAMERICAN EMAN opened at $0.47 on Wednesday. eMagin has a 52-week low of $0.46 and a 52-week high of $1.80.

eMagin (NYSEAMERICAN:EMAN) last released its quarterly earnings data on Thursday, May 9th. The semiconductor company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). The company had revenue of $6.11 million for the quarter, compared to analysts’ expectations of $6.30 million. During the same period in the previous year, the firm earned ($0.05) earnings per share.

eMagin Company Profile

eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode (OLED) displays on-silicon micro displays; virtual imaging products that utilize OLED micro displays; and related products. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS and OLED-XL; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL/XLS.

See Also: Bear Market – How and Why They Occur

Get a free copy of the Zacks research report on eMagin (EMAN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.